Goldfinch Biopharma Investors

29 investors on Angel Roster list Goldfinch Biopharma in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States and Hong Kong.

Investors are matched on the company name in their portfolio, so companies that share the name Goldfinch Biopharma can appear together.

Investors listed
29
With verified email
31%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 29 Goldfinch Biopharma investors

The most complete profiles first. Showing 29 of 29.

  • Christoph LengauerVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Craig MuirVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Eli CasdinVerified

    Venture Capital, Founder, Micro VC · United States

    SeedHealth CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more

    Verified email available

  • Robert TepperVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Andrew PangVerified

    Venture Capital, Private Equity Firm · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Verified email available

  • Brian BulgerVerified

    Investment Bank · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Verified email available

  • Jason MehringVerified

    Investment Bank, Finance Operator · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Verified email available

  • Michael LeitnerVerified

    Investment Bank · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Verified email available

  • Noreen RizviVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Abbie Celniker

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 54 more

    Contact details available

  • Cary Pfeffer

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • George Xu

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Mark Levin

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceEducation

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Neil Exter

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Adeline Oursler

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Barney Han

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Charles Chon

    Venture Capital, Private Equity Firm · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Charlie Guyton

    Investment Bank · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Contact details available

  • Cody Tranbarger

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Daniel Nellis

    Investment Bank, Finance Operator · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Contact details available

  • Kelly Moynihan

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Kush Kothary

    Investment Bank · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Contact details available

  • Laurence Paredes

    Investment Bank, Finance Operator · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Contact details available

  • Mark Kronfeld

    Investment Bank · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Contact details available

  • Nik Singhal

    Investment Bank · United States

    Health CareTelecommunicationsE-commerceCybersecurity

    Portfolio: Acorns, Goldfinch Biopharma, Domo, Icelandic Glacial and 80 more

    Contact details available

  • Reese Yeh

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Tinnie Chau, CFA

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Walter Kowtoniuk

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • William Motley

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

Frequently asked questions

How many Goldfinch Biopharma investors are on Angel Roster?

Angel Roster lists 29 Goldfinch Biopharma investors. 9 of them (31%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (18), Private Equity Firms (11) and Investment Banks (9). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Goldfinch Biopharma investors invest in?

Among those that list a stage, the most common are Seed (9).

Where are Goldfinch Biopharma investors based?

Most are based in the United States (24) and Hong Kong (2).

Which companies have Goldfinch Biopharma investors backed?

The most-backed portfolio companies among them are Insitro (24), Decibel Therapeutics (24), Constellation Pharmaceuticals (15), Fulcrum Therapeutics (15) and Celsius Therapeutics (15).

How do I contact Goldfinch Biopharma investors?

Create a free Angel Roster account to search and filter all 29, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.